Seeding after radiofrequency ablation of hepatocellular carcinoma in patients with cirrhosis: A prospective study

Digestive and Liver Disease

Volumn 40, Issue 8, 2008, Pages 684-689

  Latteri, F ^a   Sandonato, L ^a   Di Marco, V ^a   Parisi, P ^a   Cabibbo, G ^a   Lombardo, G ^a   Galia, M ^a   Midiri, M ^a   Latteri, M A ^a   Craxi A ^a  

^a UNIVERSITY OF PALERMO   (Italy)

Author keywords

Cirrhosis; Hepatocellular carcinoma; Neoplastic seeding; Radiofrequency ablation

Indexed keywords

ADULT; AGED; ARTICLE; CANCER INVASION; CANCER RISK; CANCER STAGING; CHEMOEMBOLIZATION; CLINICAL TRIAL; COHORT ANALYSIS; COMORBIDITY; CONFIDENCE INTERVAL; ECHOGRAPHY; FEMALE; FOLLOW UP; HUMAN; LAPAROTOMY; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER RESECTION; MAJOR CLINICAL STUDY; MALE; METASTASIS; PATIENT SELECTION; RADIOFREQUENCY ABLATION; RISK ASSESSMENT; SPIRAL COMPUTER ASSISTED TOMOGRAPHY; SURGICAL APPROACH; TREATMENT RESPONSE;

AGED; CARCINOMA, HEPATOCELLULAR; CATHETER ABLATION; CLINICAL PROTOCOLS; FEMALE; HUMANS; LIVER CIRRHOSIS; LIVER NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM SEEDING; PROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 45849118352     PISSN: 15908658     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.dld.2007.12.021     Document Type: Article

References (32)

1. Llovet J.M., Burroughs A., and Bruix J. Hepatocellular carcinoma. Lancet 362 (2003) 1907-1917
2. Lencioni R.A., Allgaier H.P., Cioni D., Olschewski M., Deibert P., Crocetti L., et al. Small hepatocellular carcinoma in cirrhosis: randomized comparison radio-frequency thermal ablation versus percutaneous ethanol injection. Radiology 228 (2003) 235-240
3. Lin S.M., Lin C.J., Lin C.C., Hsu C.W., and Chen Y.C. Radiofrequency ablation improves prognosis compared with ethanol injection for hepatocellular carcinoma < or = 4 cm. Gastroenterology 127 (2004) 1714-1723
4. Lin S.M., Lin C.J., Lin C.C., Hsu C.W., and Chen Y.C. Randomised controlled trial comparing percutaneous radiofrequency thermal ablation, percutaneous ethanol injection and percutaneous acetic acid injection to treat hepatocellular carcinoma of 3 cm or less. Gut 54 (2005) 1151-1156
5. Shiina S., Teratani T., Obi S., Sato S., Tateishi R., Fujishima T., et al. A randomized controlled trial of radiofrequency ablation with ethanol injection for small hepatocellular carcinoma. Gastroenterology 129 (2005) 122-130
6. Livraghi T., Solbiati L., Meloni M.F., Gazelle G.S., Halpern E.F., and Goldberg S.N. Treatment of focal liver tumours with percutaneous radiofrequency ablation: complications encountered in a multicenter study. Radiology 226 (2003) 441-451
7. Wood T.F., Rose D.M., Chung M., Allegra D.P., Foshag L.J., and Bilchik A.J. Radiofrequency ablation of 231 unresectable hepatic tumours: indications, limitations and complications. Ann Surg Oncol 7 (2000) 593-600
8. Bowles B.J., Machi J., Limm W.M., Severino R., Oishi A.J., Furumoto N.L., et al. Safety and efficacy of radiofrequency thermal ablation in advanced liver tumours. Arch Surg 136 (2001) 864-869
9. De Baere T., Risse O., Kuoch V., Dromain C., Sengel C., Smayra T., et al. Adverse events during radiofrequency treatment of 582 hepatic tumours. Am J Roentgenol 181 (2003) 695-700
10. Llovet J.M., Vilana R., Bru C., Bianchi L., Salmeron J.M., Boix L., et al. Increased risk of tumour seeding after percutaneous radiofrequency ablation for single hepatocellular carcinoma. Hepatology 33 (2001) 1124-1129
11. Livraghi T. Tumour dissemination after radiofrequency ablation of hepatocellular carcinoma. Hepatology 34 (2001) 608-609
12. Bolondi L., Gaiani S., Celli N., and Piscaglia F. Tumour dissemination after radiofrequency ablation of hepatocellular carcinoma. Hepatology 34 (2001) 608
13. De Sio I., Castellano L., De Girolamo V., Di Santolo S.S., Marone A., Del Vecchio B.C., et al. Tumour dissemination after radiofrequency ablation of hepatocellular carcinoma. Hepatology 34 (2001) 609-610
14. Goldberg S.N., and Solbiati L. Tumour dissemination after radiofrequency ablation of hepatocellular carcinoma. Hepatology 34 (2001) 609
15. Poon R.T.P., Ng K.K.C., Lam C.M., Ai V., Yuen J., and Fan S.T. Radiofrequency ablation for subcapsular hepatocellular carcinoma. Ann Surg Oncol 11 (2004) 281-289
16. Livraghi T., Lazzaroni S., Meloni F., and Solbiati L. Risk of tumour seeding after percutaneous radiofrequency ablation for hepatocellular carcinoma. Br J Surg 92 (2005) 856-858
17. Jaskolka J.D., Asch M.R., Kachura J.R., Ho C.S., Ossip M., Wong F., et al. Needle tract seeding after radiofrequency ablation of hepatic tumours. J Vasc Interv Radiol 16 (2005) 485-491
18. Tarantino L., Francica G., Sordelli I., Esposito F., Giorgio A., Sorrentino P., et al. Seeding from hepatocellular carcinoma after percutaneous ablation: color Doppler ultrasound findings. Abdom Imaging 31 (2006) 69-77
19. Kato T., and Reddy K.R. Radiofrequency ablation for hepatocellular carcinoma: help or hazard?. Hepatology 33 (2001) 1336-1337
20. Bruix J., Sherman M., Llovet J.M., Beaugrand M., Lencioni R., Burroughs A.K., et al. Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European association for the study of the liver. J Hepatol 35 (2001) 421-430
21. Llovet J.M., Bru C., and Bruix J. Prognosis of hepatocellular carcinoma: the BCLC staging classification. Semin Liver Dis 19 (1999) 329-338
22. Pugh R.N.H., Murray-Lyon I.M., Dawson J.L., Pietroni M.C., and Williams R. Transection of the esophagus for bleeding oesophageal varices. Br J Surg 60 (1973) 646-664
23. Bruix J., and Llovet J.M. Prognostic prediction and treatment strategy in hepatocellular carcinoma. Hepatology 35 (2002) 519-524
24. Lopez P.M., Villanueva A., and Llovet J.M. Systematic review: evidence-based management of hepatocellular carcinoma-an updated analysis of randomized controlled trials. Aliment Pharmacol Ther 23 (2006) 1535-1547
25. Sala M., Llovet J.M., Vilana R., Bianchi L., Sole M., Ayuso C., et al. Initial response to percutaneous ablation predicts survival in patients with hepatocellular carcinoma. Hepatology 40 (2004) 1352-1360
26. Bruix J., Sherman M., Practice Guidelines Committee, and American Association for the Study of Liver Diseases. Management of hepatocellular carcinoma. Hepatology 42 (2005) 1208-1236
27. Kim S.H., Lim H.K., Lee W.J., Cho J.M., and Jang H.J. Needle-tract implantation in hepatocellular carcinoma: frequency and CT findings after biopsy with a 19.5-gauge automated biopsy gun. Abdom Imaging 25 (2000) 246-250
28. Durand F., Regimbeau J.M., Belghiti J., Sauvanet A., Vilgrain V., Terris B., et al. Assessment of the benefits and risks of percutaneous biopsy before surgical resection of hepatocellular carcinoma. J Hepatol 35 (2001) 254-258
29. Takamori R., Wong L.L., Dang C., and Wong L. Needle-tract implantation from hepatocellular cancer: is needle biopsy of the liver always necessary?. Liver Transpl 6 (2000) 67-72
30. Stigliano R., Marelli L., Yu D., Davies N., Patch D., and Burroughs A.K. Seeding following percutaneous diagnostic and therapeutic approaches for hepatocellular carcinoma. What is the risk and the outcome? Seeding risk for percutaneous approach of HCC. Cancer Treat Rev 33 (2007) 437-447
31. Lu W., and Wai C.T. Surgery in patients with advanced liver cirrhosis: a Pandora's box. Singapore Med J 47 (2006) 152-155
32. Martin A.P., Goldstein R.M., and Dempster J. Radiofrequency thermal ablation of hepatocellular carcinoma before liver transplantation-a clinical and histological examination. Clin Transplant 20 (2006) 695-705